查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1819913

2025 年至 2033 年药物发现资讯学市场报告（按工作流程、功能、模式、最终用户（製药公司、生物技术公司、合约研究组织等）和地区划分）

Drug Discovery Informatics Market Report by Workflow, Function, Mode, End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization, and Others), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球药物发现资讯学市场规模达 36 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 84 亿美元，2025-2033 年期间的成长率 (CAGR) 为 9.21%。

药物研发资讯学是一种用于分析和解读大量生化资料的技术解决方案。这些资料源自于临床实验室为研究目的而进行的实验，并用于为各种药物的研发提供见解。它涉及众多基于软体和硬体的工具，用于药物研发的定序、标靶资料分析、资料视觉化、对接、分子建模和资料库保护。因此，它被医疗机构、製药和生物技术组织以及合约研究组织 (CRO) 广泛应用。

全球医疗保健和製药行业的显着增长是市场前景乐观的关键因素之一。此外，慢性疾病的日益普及以及对治疗罕见疾病的有效解决方案的需求不断增长，也促进了市场的成长。药物发现资讯学被製药机构广泛用于分析新药实体和处理来自多个来源的生物资讯。此外，各种技术进步，例如基于生理的药物动力学 (PBPK) 模拟器平台的开发，该平台透过建模和模拟帮助预测药物动力学结果，也是其他成长诱导因素。同时，政府和私人医疗机构加大对孤儿药研发的投资也促进了市场的成长。其他因素，包括老年人口的成长以及生物资讯学领域广泛的研发活动，预计将进一步推动市场的发展。

本报告回答的关键问题：

  • 全球药物发现资讯学市场迄今表现如何？未来几年将如何表现？
  • COVID-19 对全球药物发现资讯学市场有何影响？
  • 主要的区域市场有哪些？
  • 根据工作流程，市场是如何分類的？
  • 根据功能对市场进行怎样的细分？
  • 根据模式，市场区隔是怎么样的？
  • 根据最终用户，市场是如何分類的？
  • 该产业的价值链分为哪些阶段？
  • 该行业的主要驱动因素和挑战是什么？
  • 全球药物发现资讯学市场的结构是怎么样的？主要参与者是谁？
  • 产业竞争程度如何？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球药物发现资讯学市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依工作流程

  • 药物研发
  • 药物开发

第七章：市场区隔：依功能

  • 序列分析平台
  • 分子建模
  • 分子对接
  • 临床试验数据管理
  • 其他的

第八章：市场区隔：依模式

  • 外包
  • 内部

第九章：市场区隔：依最终用户

  • 製药公司
  • 生技公司
  • 合约研究组织（CRO）
  • 其他的

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 11 章：SWOT 分析

第 12 章：价值链分析

第 13 章：波特五力分析

第 14 章：价格分析

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Accenture PLC
    • Certara
    • Charles River Laboratories Inc.
    • Collaborative Drug Discovery Inc.
    • Eurofins DiscoverX Products
    • Infosys Ltd.
    • International Business Machines Corporation
    • Jubilant Biosys Limited
    • Oracle Corporation
    • PerkinElmer Inc.
    • Selvita
    • Thermo Fisher Scientific Inc.
Product Code: SR112025A3515

The global drug discovery informatics market size reached USD 3.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.4 Billion by 2033, exhibiting a growth rate (CAGR) of 9.21% during 2025-2033.

Drug discovery informatics is a technological solution used for analyzing and interpreting large volumes of biochemical data. The data is generated from the experiments conducted in clinical laboratories for research purposes and utilized for generating insights regarding the development of various drugs. It involves numerous software and hardware-based tools for sequencing, target data analysis, data visualization, docking, molecular modelling, database protection for drug discovery and development. As a result, it is widely used by healthcare institutions, pharmaceutical and biotechnology organizations and contract research organizations (CROs).

Significant growth in the healthcare and pharmaceutical industries across the globe represents one of key the factors creating a positive outlook for the market. Furthermore, the increasing prevalence of chronic medical disorders and the escalating requirement for effective solutions to treat rare diseases are also augmenting the market growth. Drug discovery informatics is widely used by pharmaceutical organizations for the analysis of new drug entities and handling of the biological information from multiple sources. Additionally, various technological advancements, such as the development of innovative Physiologically-based Pharmacokinetic (PBPK) Simulator platforms, which aid in predicting pharmacokinetic outcomes through modeling and simulation, are acting as other growth-inducing factors. In line with this, increasing investments by government and private healthcare institutions to develop orphan drugs is also contributing to the market growth. Other factors, including the rising geriatric population, along with extensive research and development (R&D) activities in the field of bioinformatics, are anticipated to drive the market further.

Key Market Segmentation:

Breakup by Workflow:

  • Drug Discovery
  • Drug Development

Breakup by Function:

  • Sequence Analysis Platforms
  • Molecular Modelling
  • Molecular Docking
  • Clinical Trial Data Management
  • Others

Breakup by Mode:

  • Outsourced
  • In-house

Breakup by End User:

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organization (CROs)
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Accenture Plc, Certara, Charles River Laboratories Inc., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products, Infosys Ltd., International Business Machines Corporation, Jubilant Biosys Limited, Oracle Corporation, PerkinElmer Inc., Selvita and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global drug discovery informatics market performed so far and how will it perform in the coming years ?
  • What has been the impact of COVID-19 on the global drug discovery informatics market ?
  • What are the key regional markets ?
  • What is the breakup of the market based on the workflow ?
  • What is the breakup of the market based on the function ?
  • What is the breakup of the market based on the mode ?
  • What is the breakup of the market based on the end user ?
  • What are the various stages in the value chain of the industry ?
  • What are the key driving factors and challenges in the industry ?
  • What is the structure of the global drug discovery informatics market and who are the key players ?
  • What is the degree of competition in the industry ?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Drug Discovery Informatics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Workflow

  • 6.1 Drug Discovery
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Drug Development
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Function

  • 7.1 Sequence Analysis Platforms
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Molecular Modelling
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Molecular Docking
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Clinical Trial Data Management
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Mode

  • 8.1 Outsourced
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 In-house
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Pharmaceutical Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Biotechnology Companies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Contract Research Organization (CROs)
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Accenture PLC
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Certara
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Charles River Laboratories Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Collaborative Drug Discovery Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Eurofins DiscoverX Products
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Infosys Ltd.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 International Business Machines Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Jubilant Biosys Limited
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Oracle Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 PerkinElmer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Selvita
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Drug Discovery Informatics Market: Major Drivers and Challenges
  • Figure 2: Global: Drug Discovery Informatics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Drug Discovery Informatics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Drug Discovery Informatics Market: Breakup by Workflow (in %), 2024
  • Figure 5: Global: Drug Discovery Informatics Market: Breakup by Function (in %), 2024
  • Figure 6: Global: Drug Discovery Informatics Market: Breakup by Mode (in %), 2024
  • Figure 7: Global: Drug Discovery Informatics Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Drug Discovery Informatics Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Drug Discovery Informatics (Drug Discovery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Drug Discovery Informatics (Drug Discovery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Drug Discovery Informatics (Drug Development) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Drug Discovery Informatics (Drug Development) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Drug Discovery Informatics (Sequence Analysis Platforms) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Drug Discovery Informatics (Sequence Analysis Platforms) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Drug Discovery Informatics (Molecular Modelling) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Drug Discovery Informatics (Molecular Modelling) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Drug Discovery Informatics (Molecular Docking) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Drug Discovery Informatics (Molecular Docking) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Drug Discovery Informatics (Clinical Trial Data Management) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Drug Discovery Informatics (Clinical Trial Data Management) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Drug Discovery Informatics (Other Functions) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Drug Discovery Informatics (Other Functions) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Drug Discovery Informatics (Outsourced) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Drug Discovery Informatics (Outsourced) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Drug Discovery Informatics (In-house) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Drug Discovery Informatics (In-house) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Drug Discovery Informatics (Pharmaceutical Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Drug Discovery Informatics (Pharmaceutical Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Drug Discovery Informatics (Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Drug Discovery Informatics (Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Drug Discovery Informatics (Contract Research Organization (CROs)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Drug Discovery Informatics (Contract Research Organization (CROs)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Drug Discovery Informatics (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Drug Discovery Informatics (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: North America: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: North America: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: United States: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: United States: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Canada: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Canada: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Asia-Pacific: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Asia-Pacific: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: China: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: China: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Japan: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Japan: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: India: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: India: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: South Korea: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: South Korea: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Australia: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Australia: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Indonesia: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Indonesia: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Others: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Others: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Europe: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Europe: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Germany: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Germany: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: France: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: France: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: United Kingdom: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: United Kingdom: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Italy: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Italy: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Spain: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Spain: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Russia: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Russia: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Others: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Others: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Latin America: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Latin America: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Brazil: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Brazil: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Mexico: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Mexico: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Others: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Others: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Middle East and Africa: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Middle East and Africa: Drug Discovery Informatics Market: Breakup by Country (in %), 2024
  • Figure 83: Middle East and Africa: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Global: Drug Discovery Informatics Industry: SWOT Analysis
  • Figure 85: Global: Drug Discovery Informatics Industry: Value Chain Analysis
  • Figure 86: Global: Drug Discovery Informatics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Drug Discovery Informatics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Drug Discovery Informatics Market Forecast: Breakup by Workflow (in Million USD), 2025-2033
  • Table 3: Global: Drug Discovery Informatics Market Forecast: Breakup by Function (in Million USD), 2025-2033
  • Table 4: Global: Drug Discovery Informatics Market Forecast: Breakup by Mode (in Million USD), 2025-2033
  • Table 5: Global: Drug Discovery Informatics Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Drug Discovery Informatics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Drug Discovery Informatics Market: Competitive Structure
  • Table 8: Global: Drug Discovery Informatics Market: Key Players